---
title: "Chief Commercial Officer Michael Chi Reports Disposal of Common Shares in Hims & Hers Health Inc"
description: "Michael Chi, Chief Commercial Officer of Hims & Hers Health Inc., has reported the disposal of common shares in the company. The full filing is available through the provided link. This news was gener"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258571525.md"
published_at: "2025-09-23T17:07:06.000Z"
---

# Chief Commercial Officer Michael Chi Reports Disposal of Common Shares in Hims & Hers Health Inc

> Michael Chi, Chief Commercial Officer of Hims & Hers Health Inc., has reported the disposal of common shares in the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. Hims & Hers Health Inc. is responsible for the original content published via EDGAR on September 19, 2025.

Michael Chi, the Chief Commercial Officer of Hims & Hers Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001773751-25-000312), on September 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [HIMS.US - Hims & Hers Health](https://longbridge.com/en/quote/HIMS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk reicht Patentanmeldung gegen Hims & Hers wegen Semaglutid-Produkten ein | Novo Nordisk A/S has filed a patent application for US Patent 8,129,343 against Hims & Hers regarding Semaglutide produc | [Link](https://longbridge.com/en/news/275312528.md) |
| Hims & Hers Acquires Livewell to Launch Canadian Expansion | Hims & Hers Health Inc. has acquired Livewell, a Canadian digital health provider, to expand into the Canadian market. T | [Link](https://longbridge.com/en/news/268598929.md) |
| Arteris Inc. CEO Charles Janac Reports Sale of Common Shares | Charles K. Janac, CEO of Arteris Inc., reported the sale of common shares as a beneficial owner. The full filing is avai | [Link](https://longbridge.com/en/news/275675466.md) |
| SmartFinancial Inc. Chairman Wesley Miller Reports Acquisition of Common Shares | Wesley Miller Welborn, Chairman of SmartFinancial Inc., has reported the acquisition of common shares of the company. Th | [Link](https://longbridge.com/en/news/275517093.md) |
| Director Jorge Titinger Reports Sale of FormFactor Inc. Common Shares | Jorge Titinger, Director at FormFactor Inc., has reported the sale of common shares of the company. The full filing is a | [Link](https://longbridge.com/en/news/275519004.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.